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MRI assessment of altered dynamic
changes in liver haemodynamics following
a meal challenge in compensated cirrhosis
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Abstract
Background: The aim was to use magnetic resonance imaging (MRI) to dynamically assess postprandial changes in
hepatic and collateral blood flow, liver perfusion and oxygenation in healthy participants and patients with liver
disease with compensated cirrhosis (CC).
Methods: We evaluated blood flow in the portal vein, hepatic artery and azygos vein (using phase-contrast MRI),
liver perfusion (using arterial spin labelling) and blood oxygenation (using transverse relaxation time [T2*] mapping).
Measures were collected at baseline and at 6–7-min intervals from 20 to 65 min following a test meal (440 mL,
660 kcal) in 10 healthy participants and 10 patients with CC.
Results: In healthy participants, we observed a significant postprandial increase in portal vein flow from baseline
(+ 137 ± 26% (mean ± standard deviation), p < 0.001) coupled with a reduction in hepatic artery flow from baseline
(− 30 ± 18%, p = 0.008), reflecting the hepatic artery buffer response. In patients with CC, a lower but still significant
increase in portal vein flow (67 ± 50%, p = 0.014) was observed, without a clear hepatic artery buffer response.
Healthy participants showed a significant increase in postprandial liver perfusion (138 ± 75%, p < 0.001), not observed in
patients with CC. There was no change in liver T2* for either group.
Conclusions: Postprandial changes in liver perfusion, oxygenation and hepatic and collateral circulation can be
measured noninvasively using MRI. Differences between healthy participants and patients with CC were shown,
which may help stratify liver cirrhosis in patients.
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Key points
 Phase-contrast flow measurements in healthy
participants reflect the hepatic artery buffer
response
 The hepatic artery buffer response was reduced in
patients with compensated cirrhosis
 A postprandial increase in liver tissue perfusion was
observed in healthy participants, not in patients
Background
Portal hypertension is the most critical complication of
liver cirrhosis, in which alterations in hepatic architec-
ture lead to increased portal blood flow and intrahepatic
resistance. Food intake increases splanchnic blood flow
(postprandial hyperaemia) and the postprandial response
varies with disease. In cirrhosis, the inability of the hep-
atic microcirculation to vasodilate in response to post-
prandial hyperaemia provokes a rise in collateral blood
flow and portal pressure [1]. However, the mechanism
remains unclear [2].
The noninvasive assessment of sequential postprandial
measurements of collateral blood flow, portal haemo-
dynamics and oxygenation could provide insights into the
capacity for dynamic change within the liver. Previous
studies [1–6] have assessed individual components of this
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dynamic change, but have not comprehensively assessed
the dynamic change in flow, perfusion and oxygenation
within the liver.
Potential methods to assess the postprandial response
include portal pressure assessment using the hepatic
venous pressure gradient [1–4]. However, this approach
is invasive and not widely available, thus repeated dynamic
postprandial measurements are not feasible in clinical
practice. Doppler ultrasound studies measuring portal
vein flow have shown that the postprandial response is
blunted in patients with chronic liver disease compared
with healthy participants [5, 6], but these measures have
poor reproducibility, with a high intra-observer and
inter-observer variability [6–9]. Phase contrast (PC) mag-
netic resonance imaging (MRI) data can be collected for
two-dimensional flow in which individual vessels are inter-
rogated [10–12] or, more recently, for four-dimensional
flow, allowing the assessment of several vessels in a single
scan [13], though this comes at the cost of a significantly
lengthened acquisition time [14]. PC-MRI methods have
been shown to provide improved reproducibility over
Doppler ultrasound [10–12, 15]. Previous PC-MRI studies
of the postprandial response have shown either no post-
prandial difference between healthy participants and pa-
tients with liver disease [10] or reduced postprandial
portal venous flow in patients with portal hypertension
compared to healthy participants [16]. Liver stiffness mea-
surements (LSM) using transient elastography or mag-
netic resonance elastography have shown a postprandial
increase in liver stiffness in healthy participants, which is
more pronounced and progressively increased with liver
disease severity [17, 18]. However, since LSM have contri-
butions from both a static component reflecting hepatic
fibrosis progression and a dynamic component reflecting
extrinsic perfusion changes, interpreting LSM alone to as-
sess underlying changes in postprandial portal flow and
intrahepatic resistance is challenging.
Multiparametric liver MRI permits the repeat assess-
ment of haemodynamic and oxygenation measures
within a single scan session. Hepatic and collateral blood
flow, liver perfusion and liver oxygenation can be mea-
sured using PC-MRI, arterial spin labelling (ASL) and
transverse relaxation time (T2*) mapping through blood
oxygen-level-dependent MRI, respectively. Independent
changes in blood flow to the liver and oxygen consump-
tion within the liver will influence liver blood oxygen-
ation levels, which will be reflected by changes in the
liver T2*, and measurement of blood flow and perfusion
allows these contributions to be separated. Furthermore,
since MRI is noninvasive, sequential postprandial assess-
ments are feasible and acceptable.
To date, only a few studies have assessed haemodynamic
components of the postprandial response of the liver
using MRI in healthy participants [13, 16, 19–22] or in
patients with liver cirrhosis [13, 16, 19, 20]. However, it is
difficult to compare results between these studies because
a wide variety of meals have been used and measurements
have been made at different times following ingestion of
the meal, ranging from 15 to 150 min.
Our aim was to evaluate the sequential dynamic postpran-
dial changes in hepatic and collateral circulation, liver perfu-
sion and oxygenation using quantitative MRI in healthy
participants and patients with compensated cirrhosis (CC).
Methods
Study population
A total of 10 healthy subjects (5 male and 5 female;
age 30 ± 10 years (mean ± standard deviation), range
22–56 years) and 10 patients with CC (8 male and 2 fe-
male; age 59 ± 11 years, range 38–68 years) were recruited.
Healthy participants had no history of liver disease or sig-
nificant alcohol consumption. Enrolled patients had histo-
logical or radiological evidence of liver cirrhosis. Exclusion
criteria included previous liver decompensation (ascites,
variceal bleeding or overt encephalopathy), hepatocellular
carcinoma, orthotopic liver transplantation, portal or hep-
atic vein thrombosis, beta-blocker therapy, contraindica-
tions for MRI, age below 18 years, pregnancy and portal
vein thrombosis.
The study was carried out according to the principles
of the Declaration of Helsinki. Approval for the healthy
participant study was granted by the local research ethics
committee. Approval for the patient study was granted by
East Midlands Research Ethics Committee – Nottingham
1 (Ref 12/EM/0401). Written informed consent was ob-
tained from all participants.
Study design
The study design is illustrated in Fig. 1. All participants
were scanned following a 6-h fast. MRI scans were carried
out between 8 am and 12 pm, except for one healthy par-
ticipant and one patient with CC who were scanned in the
afternoon. Baseline MRI measurements of localiser scans
followed by assessment of hepatic and collateral blood
flow, liver perfusion and liver T2* in triplicate were ini-
tially acquired. Thereafter, participants were taken out of
the scanner and they then drank a 440-mL liquid test meal
composed of 22 g fat, 89 g carbohydrate, and 28 g protein
for a total of 660 kcal (Ensure Plus, Abbott, Utrecht, The
Netherlands). The onset of meal ingestion was taken as
time T = 0 min and the meal was ingested within 5 min.
Subjects then re-entered the scanner to allow planning
localiser scans to again be collected prior to repeating the
scans at intervals of about 6-7 min (breathing-rate
dependent) from T = 20–65 min after meal ingestion. This
period was chosen as previous studies [1–3, 5, 17, 23–30]
showed peak postprandial response occurred within
this time.
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Enhanced liver fibrosis score and liver stiffness
measurement
Blood samples were obtained before and immediately
after MRI scanning, collected outside of the scanner.
Samples were analysed for alanine transaminase (ALT),
alkaline phosphatase (ALP), gamma-glutamyl transfer-
ase (GGT) and bilirubin. In addition, levels of tissue
inhibitor of matrix metalloproteinase 1 (TIMP1), hya-
luronic acid (HA), and aminoterminal peptide of pro-
collagen III (P3NP) were measured at an independent
reference laboratory (iQur Limited, London, UK) in
order to calculate an enhanced liver fibrosis (ELF) score
[31].
Healthy participants also took part in a separate study
session on a different day in which LSM was performed
at baseline and at 15-min intervals following the inges-
tion of the test meal, up to 60 min. LSM was performed
by experienced operators using FibroScan® (Echosens,
Paris, France) with 10 readings obtained to calculate me-
dian LSM. Patients did not attend on a different day for
the LSM because the postprandial change in LSM dur-
ing a meal has been reported across varying degrees of
liver fibrosis [17]. We attempted to measure the LSM in
the patients before the meal challenge and after 60 min
in the MRI scanner.
MRI acquisition
MRI scans were acquired on a 3-T Achieva scanner
(Philips Medical Systems, Best, The Netherlands) using a
multi-transmit body coil (16-channel sensitive encoding
torso receive coil). First, multi-slice balanced turbo field
echo data were acquired in three orthogonal planes to
locate the liver and vessels.
Hepatic and collateral blood flow
PC-MRI data were collected to assess hepatic (portal
vein, hepatic artery) and collateral (azygos vein) blood
flow. A turbo field echo sequence with imaging slice
placed perpendicular to each vessel was used to collect
N phases across the cardiac cycle (turbo factor 4–6,
heart-rate dependent, Table 1). The portal vein was mea-
sured before its split into right and left portal veins; the
hepatic artery was measured after splitting from the
coeliac artery; and the azygos vein was measured be-
tween the azygos arch and the accessory hemiazygos
vein. Each PC-MRI measurement was acquired during a
15–20-s breath hold.
Liver perfusion
Multiphase flow-sensitive alternating inversion recovery
ASL data (30 selective/non-selective pairs) were col-
lected with a balanced fast field echo readout (centric
half-Fourier acquisition, shot duration 130 ms, Table 1)
in a sagittal slice through the right lobe of the liver,
avoiding major vessels. Data were collected with a
respiratory trigger delay of 500 ms prior to the ASL
labelling. Labelling was followed by Look-Locker sam-
pling (initial delay 100 ms, subsequent readout spacing
350 ms) with six readout phases collected to span
post-label delay times of 100–1850 ms [32]. A base
magnetization (M0) image was also collected for per-
fusion quantification.
Liver T2* mapping
A multi-echo fast field echo sequence was used to obtain
8 contiguous axial slices (echo spacing 2.5 ms, 12
echoes, Table 1). Each T2* measurement was collected
during a 17-s breath hold.
Fig. 1 Magnetic resonance imaging (MRI) protocol comprising serial measurements. Measurements were collected in triplicate at baseline and
then repeated from time (T) = 20–65 min following meal ingestion. Measurements were collected to assess blood flow to the liver and collateral
flow (using phase contrast sequences), liver tissue perfusion (using the arterial spin labelling (ASL) technique) and liver transverse relaxation time
(T2*), an indirect marker of oxygenation
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Magnetic resonance imaging analysis
Hepatic and collateral blood flow
For each vessel, the mean vessel cross-sectional area
(mm2), velocity (cm/s) and hence, flow (mL/s), across
the cardiac cycle was calculated using Q-flow software
(Philips Medical Systems, Best, The Netherlands). Total
hepatic blood flow (THBF) was calculated from the sum
of the portal vein and hepatic artery blood flow. Azygos
vein flow was used to indicate collateral blood flow.
Liver perfusion
In-house programs were used to quantify perfusion
(mL/100 g/min) from ASL data (MATLAB, The Math-
Works Inc., Natick, MA, USA). Individual difference im-
ages (selective minus non-selective) were calculated and
averaged to form perfusion-weighted difference (ΔM)
maps for each post-label delay. Non-selective images
were used to perform a voxel-wise fit for longitudinal re-
laxation time, T1. A liver mask was formed from the
base M0 image and applied to the T1 map to form a
histogram of liver T1 values. Histogram analysis assessed
the mode (μ) and standard deviation (SD) of the T1 dis-
tribution across the liver. A liver tissue mask was formed
from voxels with T1 = μ ± SD, and a liver vessel mask
from voxels with T1 > (μ + SD). Mean values of ΔM, T1
and M0 for liver tissue were used in an iterative model
[33, 34] to calculate liver tissue perfusion and arrival
time of the labelled blood to the liver tissue, assuming a
blood T1 relaxation time of 1.55 s at 3 T.
Liver T2* mapping
The log of the exponential transverse signal decay was
fit for T2* (MATLAB, The MathWorks Inc., Natick,
MA, USA). A histogram of liver T2* values was formed
and the mode and full width at half maximum (FWHM)
of the T2* distribution computed.
Statistics
Statistical analysis was performed using SPSS software
version 21(IBM, New York, USA), with p values < 0.05
considered as statistically significant. Normality was
tested using the Shapiro-Wilk test. Normal data are
given as mean ± SD, else median and interquartile range
is given. Groups were compared using the independent
samples two-tailed t test if data were normally distrib-
uted, else the Mann-Whitney U test. Changes between
baseline and postprandial time points were analysed
using the paired t test when time-points were normally
distributed, else the related-samples Wilcoxon signed
rank test. The Bonferroni correction for multiple compari-
sons was applied. Within-session baseline repeatability of
MRI measurements was calculated using the coefficient of
variation (CoV) and intra-class correlation (ICC, two-way
mixed, absolute agreement, average measures).
Results
Clinical and biochemical parameters of the patients with
CC are presented in Table 2. Diagnosis of cirrhosis was
established either from a liver biopsy (n = 9) or an abdom-
inal ultrasound (n = 1). All patients had a Childs-Pugh
score < 6 points (Childs-Pugh A). Nine patients underwent
oesophagogastroduodenoscopy within 2 years of the
study. Five patients had no evidence of gastro-oesophageal
varices and four patients had evidence of small grade-1
varices.
Baseline measures
Figure 2 provides serum levels of ALT, ALP, GGT and
bilirubin at baseline in healthy participants and patients
with CC. All healthy participants had normal serum
levels at baseline, while serum levels of ALP and GGT
were significantly higher in Patients with CC. As ex-
pected, baseline ELF score and constituent serum levels
were significantly higher in Patients with CC compared
Table 1 Magnetic resonance parameters for blood flow assessment using phase contrast magnetic resonance imaging, liver
perfusion measures using arterial spin labelling (ASL) and transverse relaxation (T2*) mapping of the liver
Parameter Phase contrast ASL T2*
Portal vein Hepatic artery Azygos vein
Reconstructed voxel (mm3) 1.17 × 1.17 × 6 1.17 × 1.17 × 6 1.17 × 1.17 × 6 3 × 3 × 5 1 × 1 × 8
Repetition time (ms) 8.4 5.6 7.5 2.9 365
Echo time (ms) 3.7 3.2 3.7 1.45 2.5
Flip angle (°) 25 25 25 45 30
SENSE factor 2 2 2 2 2.5
Velocity encoding (cm/s) 50 Baseline 100
Postprandial 150
50 NA NA
Phases (number) 20 30 20 NA NA
SENSE sensitivity encoding, NA not available
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to healthy participants (Fig. 2). Baseline LSM for healthy
participants was 4.1 kPa (range 3.6–4.4).
Baseline MRI measures are listed in Table 3 with the
associated CoV and ICC. The CoV of vessel flow param-
eters were between 2.5 and 15.4%. The area of the portal
vein was larger in patients with CC compared to healthy
participants, whilst portal vein blood flow velocity was
similar between groups, resulting in significantly higher
portal vein blood flow in patients with CC than in healthy
participants. There were no differences between groups in
velocity, area or flow in the hepatic artery, thus the higher
THBF in patients with CC was dominated by increased
portal vein flow. Azygos vein flow was significantly higher
in patients with CC than in healthy participants. There
was no difference between groups in liver tissue perfusion,
whilst arrival time of blood to the liver tissue was shorter
in patients with CC compared with healthy participants
(Table 3). There was no difference in liver tissue T2* be-
tween groups, despite an excellent CoV (< 2.5%). ICCs
were good for all parameters (> 0.77), in particular for all
PC-MRI and T2* measures (> 0.93).
Postprandial response
Figure 2 shows serum levels at baseline and T = 70 min.
In healthy participants, there was no change in levels of
ALT, ALP and GGT, whilst the reduction in serum bili-
rubin by 1.1 μmol/L was significant. In patients with CC,
serum levels of ALT, ALP and GGT significantly de-
creased postprandial, with no change in serum bilirubin
level. Among healthy participants there were no post-
prandial changes in TIMP1 or P3NP concentration;
however, there was an increase in hyaluronic acid (HA)
Fig. 2 Serum markers at baseline and at time (T) = 70 min following meal ingestion in healthy participants (HV) and patients with compensated
cirrhosis (CC). ALT alanine transaminase; ALP alkaline phosphatase; GGT gamma-glutamyl transferase; HA hyaluronic acid; TIMP tissue inhibitor of
matrix metalloproteinase 1; P3NP aminoterminal peptide of procollagen III; ELF enhanced liver fibrosis. *p < 0.05, **p < 0.01
Table 2 Clinical and laboratory data for the patients with
compensated cirrhosis
Variables Patients with compensated
cirrhosis (n = 10)
Aetiology (n)
Alcohol 6
Non-alcoholic fatty liver disease 2





Albumin (g/L) 40.5 ± 3.7
Prothrombin time (s) 10.6 ± 0.7
Platelet count (× 109/L) 229.6 ± 122.9
Serum sodium (mmol/L) 139.0 ± 3.3
Serum creatinine (μmol/L) 72.4 ± 16.4
Data are numbers (frequencies) or mean ± standard deviation
n number
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and therefore in ELF score. In patients with CC, levels of
P3NP and TIMP1 decreased, but HA and the composite
ELF score did not change. In healthy participants, the
predicted postprandial increase in LSM was evident
(Fig. 3), with the maximum increase from baseline at
T = 30 min (p = 0.003).
Figure 4 shows the change from baseline in postprandial
blood flow measures. Maximum increase in portal vein
flow from baseline occurred at about T = 30 min and was
considerably larger in healthy participants (137 ± 26%,
p < 0.001) than in patients with CC (67 ± 50%, p = 0.014).
This increase resulted from the rise in portal vein velocity
and vessel dilation (Fig. 4). In healthy participants, hepatic
artery flow decreased postprandial (30 ± 18% reduction at
T = 24 min, p = 0.008), which persisted during the study
period. In contrast, there was no postprandial change in
patients with CC. Postprandial vasoconstriction of the
hepatic artery (16–21% during the postprandial study
period) coupled with a reduction in blood flow velocity
(35 ± 18% reduction at T = 49 min, p = 0.008) led to the re-
duced hepatic artery flow observed in the healthy partici-
pants. Postprandial THBF increased in both groups, with
a larger increase in healthy participants (Fig. 4).
In healthy participants, azygos vein flow increased
continually for the entire postprandial study period,
reaching 109 ± 64% above baseline. This rise was driven
by the continual increase in azygous blood flow velocity
(0.032 at T = 65 min). There was no change in the area
of the azygos vein in either group. In the patients with
CC, azygos blood velocity, and therefore flow, increased
at T = 25 min (34 ± 56% and 22 ± 31% for flow and vel-
ocity respectively) and remained elevated for the study
duration, although this did not reach significance.
Liver tissue perfusion increased postprandial in both
groups (Fig. 5), with a greater increase in healthy partici-
pants than in patients with CC. In both groups this in-
crease was sustained during the postprandial study
period. A maximum rise from baseline was seen in
healthy participants at T = 39 min (138 ± 75%, p < 0.001)
and in the patients with CC at T = 28 min (51 ± 58%). In
both groups, increased perfusion was associated with a
Table 3 Baseline magnetic resonance imaging flow, perfusion, and transverse relaxation time (T2*) data for healthy participants and
patients with compensated cirrhosis (CC)




Baseline CoV (%) Baseline CoV (%)
Portal vein Area (mm2) 94.4 ± 25.5 7.3 ± 4.4 138.5 (92.4–141.7) 3.8 ± 2.6 0.063 0.984
Velocity (cm/s) 13.2 ± 2.7 9.4 ± 7.6 13.7 ± 2.9 4.9 (4.2–5.6) 0.694 0.924
Flux (mL/s) 12.0 ± 3.1 6.8 (5.7–11.0) 16.3 ± 4.5 5.7 ± 1.9 0.022a 0.979
Hepatic artery Area (mm2) 24.6 ± 4.8 5.5 (3.9–7.9) 20.7 (19.8–23.4) 5.7 (2.7–8.5) 0.278 0.942
Velocity (cm/s) 18.0 ± 3.5 9.4 (7.8–19.4) 16.2 (11.5–24.2) 7.9 ± 3.5 0.720 0.985
Flux (mL/s) 4.5 ± 1.5 15.4 ± 8.5 3.5 (2.8–5.0) 7.5 ± 4.5 0.315 0.975
Total hepatic blood flow (mL/s) 16.2 ± 4.1 8.4 (5.6–9.5) 20.9 ± 5.0 5.5 ± 3.6 0.038a 0.972
Azygos vein Area (mm2) 21.6 ± 6.3 6.0 (4.3–7.4) 20.8 (18.7–33.1) 2.5 (1.0–3.5) 0.635 0.985
Velocity (cm/s) 10.1 ± 4.9 9.3 ± 4.4 13.4 ± 3.7 7.1 ± 5.0 0.144 0.977
Flux (mL/s) 2.0 ± 0.6 14.7 ± 9.7 2.9 (2.3–5.0) 8.5 ± 5.2 0.042a 0.994
Liver perfusion (mL/100 g/min) 212.9 ± 53.9 11.2 ± 12.5 219.6 ± 75.5 12.5 ± 9.1 0.826 0.773
Arrival time of blood to liver (ms) 545 (499–604) 17.1 (4.9–41.3) 367 ± 89 26.1 ± 17.2 0.034a 0.793
T2* (ms) Mode 17.8 ± 3.7 2.5 ± 1.3 14.5 ± 5.3 1.4 (1.3–2.7) 0.126 0.996
FWHM 8.8 ± 2.3 4.4 (3.8–6.1) 7.8 ± 2.1 13.1 ± 10.1 0.294 0.930
Data are mean ± standard deviation for normally distributed data or median and interquartile range for non-normally distributed data
CoV coefficient of variation, ICC intra-class correlation (ICC)
aStatistical significance
Fig. 3 Percentage change in liver stiffness measurement (LSM) from
baseline, following meal ingestion (mean ± standard error of the
mean) in healthy participants. Comparison of each time point with
baseline, *p < 0.05. T time
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shorter arrival time of the labelled blood to the liver tis-
sue. Reduced arrival time was sustained throughout the
postprandial study period for the healthy participants
(40–60% below baseline) whilst in patients with CC
there was an initial decrease at T = 21 min (42 ± 32%)
before returning towards baseline.
Both groups showed a trend for a postprandial in-
crease in liver T2* (Fig. 6), with a larger maximum in-
crease in healthy participants (7 ± 9% at T = 26 min),
compared with patients with CC (3 ± 7% at T = 34 min).
The FWHM of T2* increased significantly in healthy
participants at T = 26 min (22 ± 21%), but no change was
seen in patients with CC.
Discussion
Noninvasive, quantitative MRI has been used to measure
dynamic changes in hepatic and collateral flow, liver
tissue perfusion and oxygenation in both healthy partici-
pants and patients with CC following a test meal. Base-
line serum levels, ELF scores and LSM are in line with
those reported in the literature for healthy participants
and patients with CC [35, 36] Baseline MRI measures
were highly reproducible in healthy participants and pa-
tients with CC, suggesting these noninvasive measures
are feasible for assessing dynamic changes following a
meal. We have recently demonstrated the validation of
MRI measures in compensated cirrhosis against biopsy,
indocyanine green clearance and clinical outcomes [37].
There has now been a number of comparative studies of
reproducibility between PC-MRI and Doppler ultra-
sound, for example, demonstrating better PC-MRI
1-year reproducibility and reduced variability (combined
total liver blood flow CoV of 18% for PC-MRI versus
33% for Doppler ultrasound) [12].
Fig. 4 Percentage change in flow, area and velocity in the portal vein, hepatic artery, total hepatic blood flow (THBF) and azygos vein following
meal ingestion in healthy participants and patients with compensated cirrhosis (mean ± standard error of the mean). Absolute change in flow is
also given. Filled circles indicate healthy participants and open circles indicate patients with compensated cirrhosis. Comparison of each time
point with baseline, *p < 0.05, **p < 0.01. T time
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The reduction in serum bilirubin in healthy participants
is unlikely to represent clinical significance as all values are
well below the upper limit of the normal range (approxi-
mately 30 μmol/L). The postprandial rise in serum HA in
healthy participants has been attributed to a manifestation
of a metabolic challenge leading to a stress response in the
liver [38]. The postprandial increase in LSM at T = 30 min
in our healthy participants has previously been observed in
patients with varying stages of liver fibrosis [17].
Our MRI measures showed postprandial portal vein
flow increased in healthy participants, but was blunted
in patients with CC during the entire study period, in
agreement with Doppler ultrasound [39–41] and four-
dimensional flow MRI [16] studies. The postprandial
reduction in hepatic arterial flow in healthy partici-
pants, not seen in patients with CC, is also in keeping
with Doppler ultrasound studies where a postprandial
increase in hepatic artery resistance index diminished
with the increasing fibrosis [24, 42]. The postprandial
increase in THBF is dominated by the increase in portal
vein flux, and the reciprocal changes in the portal vein
and hepatic artery flow seen in our study are likely to
reflect the hepatic artery buffer response, which regu-
lates THBF. Multiple portal vein PC-MRI studies have
demonstrated reduced portal vein flow in chronic liver
disease and portal hypertension [10, 20]. Portal vein
PC-MRI has also been used to demonstrate the ex-
pected postprandial increase in portal vein flow and fol-
lowing trans-jugular intrahepatic portosystemic shunt
procedures [10].
A greater postprandial increase in azygos flow was
seen in healthy participants compared with patients with
CC. Here, the maximum rise occurred at the final post-
prandial time point (T = 65 min). Previously, postpran-
dial azygos vein flow measured with PC-MRI in healthy
participants was shown to increase by 38% at 30–40 min
[20], but the continued increase in azygos vein flow at
T = 65 min seen here in healthy participants has not
been reported. Thus, we speculate this reflects the per-
sistently elevated portal vein flow. However, in patients
with CC, postprandial azygos blood flow was signifi-
cantly increased after 20 min using four-dimensional
flow MRI [16] and at 30 min but not at 45 min mea-
sured invasively using a thermal dilution catheter [2].
The postprandial rise in liver perfusion was blunted in
patients with CC compared to healthy participants. This
reflects the blunting of the postprandial portal venous
flow in patients with CC, which is not compensated by
the hepatic artery flow. Recently, arterial and portal ven-
ous perfusion of the liver was studied using MRI in
healthy participants [21], with only a postprandial in-
crease in venous perfusion observed.
In healthy participants, there was a trend for a post-
prandial increase in liver T2* and significant postpran-
dial increase in the FWHM of T2*, indicating a capacity
for change not seen in patients with CC. T2* of the liver
is influenced by both iron [43] and oxygen content, here
the dynamic increase in liver T2* reflects a change in
the latter from either blood flow or oxygen consumption
changes. Previously, an increase in T2* following glucose
administration in healthy participants has been shown,
although contributions from blood flow were not mea-
sured [44]. Hepatic oxygen uptake is reduced in cirrhosis
[45] which may explain why there was no postprandial
change in T2* in patients with CC.
Studying the dynamic changes after a meal could offer
insight into key pathophysiological changes (hepatic ar-
tery buffer response and liver perfusion), which may
have critical contributions to clinical management. Al-
though the significance of hepatic artery buffer response
in patients with CC is not completely understood, it is
hypothesised that the increase in hepatic arterial flow in
Fig. 5 Percentage change in liver tissue perfusion (a) and blood
arrival time (b) to the liver following meal ingestion in healthy
participants and patients with compensated cirrhosis (mean ±
standard error of the mean). Filled circles indicate healthy
participants and open circles indicate patients with compensated
cirrhosis. Comparison of each time point with baseline, *p < 0.05,
**p < 0.01. T time
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a low portal venous flow state sustains oxygen delivery
to the liver and thus has a protective effect on organ
function [46]. We propose that studying postprandial
change in liver and collateral haemodynamics will aid
individualised treatment strategies for portal hypertension
and hence reduce the rate of treatment non-response.
Haemodynamic change following a meal challenge has
been utilised as a model to study the effects of novel treat-
ment for portal hypertension [28, 47, 48]. In patients with
extensive collateralisation and greater postprandial rise of
the collateral circulation, the efficacy of eradicating the
varices as the primary treatment strategy in reducing the
risk of bleeding should be evaluated.
This study has some limitations. Disease severity was
not homogeneous in this group of patients with CC
and we do not have any hepatic venous-pressure gradi-
ent measurements. We did not specify the presence of
diabetes mellitus in our inclusion/exclusion criteria.
This may be of particular relevance in the two patients
with non-alcoholic fatty liver disease, since significant
changes in the postprandial ALT levels have been re-
ported in participants with type 2 diabetes mellitus
compared to healthy participants [38, 39]. The age
range of the patients with CC was significantly higher
than that of the healthy participants, and two partici-
pants were scanned in the afternoon, rather than in the
morning as were the other participants. LSM were not
possible in the patients with CC as sufficient valid mea-
sures could not be obtained before and after the meal
challenge due to multiple technical factors relating to
the Fibroscan equipment. It was not feasible to also dy-
namically measure gastric emptying or intestinal motility,
which has been reported to differ between patients with
CC and healthy participants [49–51].
In conclusion, noninvasive MRI was performed dy-
namically to capture haemodynamic and oxygenation
changes in the postprandial period from T = 20 to
65 min. This provides a unique opportunity to concur-
rently study the effects of potential novel treatments for
portal hypertension on liver and collateral blood flow
and liver perfusion and oxygenation.
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